Literature DB >> 23651859

Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.

C Troedson1, M Wong, J Dalby-Payne, M Wilson, M Dexter, G I Rice, Y J Crow, R C Dale.   

Abstract

We report a female with infantile onset of systemic lupus erythematosus secondary to C1q deficiency, in whom we identified a novel homozygous mutation in C1qB. The patient developed a progressive encephalopathy associated with spasticity, and suffered several arterial ischaemic strokes. Cerebral imaging demonstrated acquired intracranial calcification and a cerebral vasculopathy reminiscent of moyamoya. This case demonstrates overlap with some features of Aicardi-Goutières syndrome which, like C1q deficiency, is a monogenic cause of inflammation involving dysregulation of the innate immune system and stimulation of a type I interferon response.

Entities:  

Keywords:  Aicardi-Goutières syndrome; C1q; lupus; moyamoya; stroke

Mesh:

Substances:

Year:  2013        PMID: 23651859     DOI: 10.1177/0961203313486950

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

Review 1.  Type I interferon in the pathogenesis of lupus.

Authors:  Mary K Crow
Journal:  J Immunol       Date:  2014-06-15       Impact factor: 5.422

Review 2.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

3.  C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Rosanne A van Schaarenburg; César Magro-Checa; Jaap A Bakker; Y K Onno Teng; Ingeborg M Bajema; Tom W Huizinga; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

Review 4.  Neutrophil extracellular traps (Nets) impact upon autoimmune disorders.

Authors:  Michał Przemysław Pruchniak; Iwona Kotuła; Aneta Manda-Handzlik
Journal:  Cent Eur J Immunol       Date:  2015-08-03       Impact factor: 2.085

Review 5.  The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.

Authors:  Aziz Bousfiha; Leïla Jeddane; Waleed Al-Herz; Fatima Ailal; Jean-Laurent Casanova; Talal Chatila; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; H Bobby Gaspar; Steven M Holland; Christoph Klein; Shigeaki Nonoyama; Hans D Ochs; Eric Oksenhendler; Capucine Picard; Jennifer M Puck; Kathleen E Sullivan; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2015-10-07       Impact factor: 8.317

6.  The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.

Authors:  Stefania Lenna; Shervin Assassi; G Alessandra Farina; Julio C Mantero; Raffaella Scorza; Robert Lafyatis; Harrison W Farber; Maria Trojanowska
Journal:  Arthritis Res Ther       Date:  2015-12-16       Impact factor: 5.156

Review 7.  Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Authors:  Mathieu P Rodero; Yanick J Crow
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

8.  Zika virus infection elicits auto-antibodies to C1q.

Authors:  Takaaki Koma; Veljko Veljkovic; Danielle E Anderson; Lin-Fa Wang; Shannan L Rossi; Chao Shan; Pei-Yong Shi; David W Beasley; Natalya Bukreyeva; Jeanon N Smith; Steven Hallam; Cheng Huang; Veronika von Messling; Slobodan Paessler
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

Review 9.  New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond.

Authors:  Erkan Demirkaya; Sezgin Sahin; Micol Romano; Qing Zhou; Ivona Aksentijevich
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

Review 10.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.